Article
Association of the genetic polymorphism of the CYP19 intron 4[TTTA]n repeat with familial prostate cancer risk in a Japanese population.
Anticancer research - 1 Jan 2000
Suzuki Kazuhiro, Nakazato Haruki, Matsui Hiroshi, Koike Hidekazu, Okugi Hironobu, Ohtake Nobuaki, Takei Tomoyuki, Nakata Seiji, Hasumi Masaru, Yamanaka Hidetoshi
Abstract excerpt
BACKGROUND: Estrogen is crucial for development of benign prostate hyperplasia and prostate cancer. Aromatase (CYP19) is a key enzyme for estrogen synthesis in males. The genetic polymorphism of the CYP19 intron 4 [TTTA]n tetranucleotide has been studied in relation to breast cancer susceptibility. MATERIALS AND METHODS: We examined the association of the tetranucleotide repeat polymorphism of the CYP19 gene with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
